GSK is paying $66 million upfront to license rights to Spero Therapeutics novel antibiotic tebipenem Hbr, unswayed by the FDA's decision earlier this year not to approve the drug for adults with ...

Indiana continues the 2024-25 season Saturday against the Ohio State Buckeyes at Simon Skjodt Assembly Hall in Bloomington.

The FDA's decision not to approve Spero Therapeutics' oral antibiotic tebipenem Hbr for adults with complicated urinary tract infections (cUTI) further increases the threat of antibiotic ...

After hours: March 10 at 7:59:28 PM EDT Loading Chart for SPRO ...

Jin’s been the flavor of the month pro play pick for many, though it’s more because he’s a consistent jack-of-all-trades than because he excels in any one area. Regardless, his killer lows ...